Company news

Solana Company (NASDAQ:HSDT) news

Solana Company news releases on 6ix. Latest, Sep 30, 2026: Solana Company (NASDAQ: HSDT) Announces Pricing of $15 Million Registered Direct Offering…

Solana Company (NASDAQ:HSDT) news

Press releases & updates

Solana Company (NASDAQ: HSDT) Announces Pricing of $15 Million Registered Direct Offering with a Global Institutional Investor

Solana Company (NASDAQ: HSDT) Announces Pricing of $15 Million Registered Direct Offering with a Global Institutional Investor

Solana Company Announces Positions and Votes on first Solana Governance Proposals

Solana : Initial Statement of Beneficial Ownership (Form 3)

Solana Company Reports First Quarter 2026 Financial Results

Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026

Jito Foundation and Solana Company (NASDAQ: HSDT) Announce Strategic Partnership to Expand Institutional Solana Infrastructure Across Asia-Pacific Region

Solana Company (NASDAQ: HSDT) Announces Registered Direct Offering of Common Stock to Global Institutional Investor

Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth

Solana Company Reports Fourth Quarter and Full Year 2025 Financial Results

Solana Company to Release Fourth Quarter and Full Year 2025 Operating Results on March 30, 2026

Solana Company (NASDAQ: HSDT) Announces Plan for the Pacific Backbone, a High-Speed Infrastructure Buildout for Solana

Solana Company Reports Third Quarter 2025 Financial Results

Solana Company to Release Third Quarter Operating Results on November 18, 2025

Solana Company (NASDAQ: HSDT) Releases Investor Update

Solana Company Files Application to Cease to Be a Reporting Issuer in Canada

CORRECTION – Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield

Solana Company NASDAQHSDT Selects BitGo as Custodian for SOL Treasury Holdings

Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings

Solana Company (NASDAQ:HSDT), Formerly Helius, Continues Amassing SOL, the Native Asset of Solana Blockchain

Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke

Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Treasury Company

Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements

Helius Medical Technologies Announces Reverse Stock Split

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device

Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results

Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024

Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke

Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference

Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier

Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS